TCL Archive In Brief: David Chambers named deputy director for implementation science at NCI DCCPS December 5, 2014
TCL Archive Coalition Members Urged To Demand Intent Of Congress In Cancer Act Be Recognized March 13, 1981
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
